Recursion Pharmaceuticals RXRX, a TechBio company that decodes biology and chemistry to industrialize drug discovery, is expected to report fourth-quarter 2025 results soon. The Zacks Consensus ...

Shares of Recursion Pharmaceuticals (RXRX) spiked on Wednesday after the AI-driven drug developer significantly exceeded Street forecasts with its Q4 2025 financials, thanks primarily to a milestone ...

Bob Dylan’s former, and well-preserved, Harlem home has a buyer. The landmarked Renaissance Revival townhouse at 265 W. 139th St. along Strivers’ Row served as Dylan’s home for 14 years. It recently ...

Public School is trying. And perhaps succeeding. By Jacob Gallagher There are no second acts in American lives, but somehow there are in American fashion. The opening day of New York Fashion Week had ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Subscribe Login Register Log out My Profile Subscriber Services Search PGe NEWSLETTERS PG STORE ARCHIVES PUBLIC NOTICES OBITUARIES JOBS CLASSIFIEDS EVENTS PETS ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...